SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-18-000058
Filing Date
2018-05-15
Accepted
2018-05-15 16:42:43
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ebio-033118x10q.htm 10-Q 520058
2 EXHIBIT 31.1 ebio-033118x311.htm EX-31.1 12081
3 EXHIBIT 31.2 ebio-033118x312.htm EX-31.2 11926
4 EXHIBIT 32.1 ebio-033118x321.htm EX-32.1 6994
  Complete submission text file 0001485003-18-000058.txt   2900594

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ebio-20180331.xml EX-101.INS 487527
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20180331.xsd EX-101.SCH 26207
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20180331_cal.xml EX-101.CAL 47791
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20180331_def.xml EX-101.DEF 102839
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20180331_lab.xml EX-101.LAB 354800
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20180331_pre.xml EX-101.PRE 209008
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 18837261
SIC: 2834 Pharmaceutical Preparations